3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
199
INDUSTRY
79
NIH
15
OTHER_GOV
11
NETWORK
2
FED
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Prostatic Neoplasms
6
Neoplasms
4
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Tobacco Use Cessation
1
Tobacco Use
1
Tinnitus
1
Solitary Pulmonary Nodule
1
Smoking
1
Small Cell Lung Carcinoma
1
Patient Compliance
1
Ototoxicity
1
Opioid-Related Disorders
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Lung Diseases, Obstructive
1
Liver Neoplasms
1
Kidney Diseases
1
Keratosis, Actinic
1
Hearing Loss, Sensorineural
1
Hearing Loss
1
Head and Neck Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Dementia
1
Deglutition Disorders
1
Colorectal Neoplasms
1
Chronic Pain
1
Interventions
Hydroxychloroquine
1
Ethiodized Oil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
FED
×
Carcinoma, Hepatocellular
×
90 days
×
Clear all
NCT05486572
2026-04-21
PREMIUM
VA Office of Research and Development
Phase NA
Recruiting
4,700 enrolled
NCT05842174
2026-04-16
TAQE
VA Office of Research and Development
Phase 1/2
Recruiting
93 enrolled